click image
to expand
use mouse
to drag
full image
click to close
Myosight™ Adult Cardiomyocyte Application specific screening module
Adult cardiomyocytes are the gold standard for testing fractional shortening changes due to drug interactions with hERG and other ion channels. Reify's population-based measurement of cardiomyocyte fractional shortening removes the need for identifying edges and time consuming manipulations increasing throughput and accuracy. Additionally, Myosight™ offers multiplex capabilities with specific ion channel probes and traditional patch clamping technology for instances where information on specific ion channels is required. For cardiac drug screening, additional parameters surrounding contraction and relaxation parameters are generated as well as contraction IC50s.
Features :